AAAAAA

   
Results: 1-7 |
Results: 7

Authors: Nielsen, SD Sorensen, TU Aladdin, H Ersboll, AK Mathiesen, L Ullum, H Gerstoft, J Nielsen, JO Pedersen, BK Nielsen, SD
Citation: Sd. Nielsen et al., The effect of long-term treatment with granulocyte colony-stimulating factor on hematopoiesis in HIV-infected individuals, SC J IMMUN, 52(3), 2000, pp. 298-303

Authors: Aladdin, H Ullum, H Schjerling, P Jensen, MS Nielsen, SD Mathiesen, L Gerstoft, J Skinhoj, P Pedersen, BK
Citation: H. Aladdin et al., Effects of G-CSF on telomere lengths in PBMCs from human immunodeficiency virus-infected patients: Results from a randomized, placebo-controlled trial, SC J IMMUN, 52(2), 2000, pp. 212-216

Authors: Nielsen, SD Sorensen, TU Ersboll, AK Ngo, N Mathiesen, L Nielsen, JO Hansen, JES
Citation: Sd. Nielsen et al., Decrease in immune activation in HIV-infected patients treated with highlyactive antiretroviral therapy correlates with the function of hematopoietic progenitor cells and the number of naive CD4(+) cells, SC J IN DIS, 32(6), 2000, pp. 597-603

Authors: Aladdin, H Ullum, H Nielsen, SD Espersen, C Mathiesen, L Katzenstein, TL Gerstoft, J Skinhoj, P Pedersen, BK
Citation: H. Aladdin et al., Granulocyte colony-stimulating factor increases CD4(+) T cell counts of human immunodeficiency virus-infected patients receiving stable, highly active antiretroviral therapy: Results from a randomized, placebo-controlled trial, J INFEC DIS, 181(3), 2000, pp. 1148-1152

Authors: Kirk, O Katzenstein, TL Gerstoft, J Mathiesen, L Nielsen, H Pedersen, C Lundgren, JD
Citation: O. Kirk et al., Combination therapy containing ritonavir plus saquinavir has superior short-term antiretroviral efficacy: a randomized trial, AIDS, 13(1), 1999, pp. F9-F16

Authors: Abrams, D Allan, D Antunes, F Breckenridge, A Bruun, J Cameron, W Carbon, C Chalmers, I Chang, H Chodakewitz, J Clendenin, N Clumeck, N Collier, A Collins, G Cooper, E Cooper, D Danner, S D'Aquila, R DeGruttola, V DeMasi, R Dee, L Deyton, L Dixon, D Farthing, C Feinberg, J Fischl, M Flepp, M Gartland, M Gatell, J Gazzard, B Goebel, F Gotzsche, P Gringeri, A Hall, D Hamilton, J Hammer, S Hartigan, P Heath-Chiozzi, M Henry, K Hill, A Hirschel, B Ioannidis, J Kahn, J Katlama, C Katzenstein, D Killen, J King, E de Loes, SK Kravcik, S Lange, J Leavitt, R Leonard, J Maeland, A Mannucci, P Mathiesen, L McDade, H Meibohn, A Melander, H Merigan, T Mulder, J Myers, M Neaton, J Nessling, M Perrin, L Pettinelli, C Phair, J Phillips, A Pinching, A Poppa, A Power, L Reiss, P Richman, D Rooney, J Rousseau, F Rutherford, G Salgo, M Sandstrom, E Saravolatz, L Savidge, G Schnittman, S Schooley, R Seligmann, M Simberkoff, M Skowron, G Slade, P Smith, D Smith, RP Soriano, V Stanley, K Stingl, G Stoffels, P Struthers, L Tierney, C Thompson, M Van der Broeck, R Van Leeuven, R Van Weverling, G Veenstra, J Vella, S Volberding, P Weber, J Winslow, D Yeni, P Yeo, J Dormont, J Sande, M Weller, I Babiker, A Collins, R Darbyshire, J Duncan, W Foulkes, M Hughes, M Peto, R Peto, T Walker, S
Citation: D. Abrams et al., Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection:meta-analyses of the randomised evidence, LANCET, 353(9169), 1999, pp. 2014-2025

Authors: Nielsen, SD Clark, DR Hutchings, M Dam-Larsen, S Repping, S Nielsen, JO Mathiesen, L Miedema, F Hansen, JES
Citation: Sd. Nielsen et al., Treatment with granulocyte colony-stimulating factor decreases the capacity of hematopoietic progenitor cells for generation of lymphocytes in human immunodeficiency virus-infected persons, J INFEC DIS, 180(6), 1999, pp. 1819-1826
Risultati: 1-7 |